Why Is Rejuran the Fastest Growing Aesthetic Treatment in 2026 — And Should You Be Booking It?
The numbers are extraordinary, and worth understanding before dismissing them as a marketing claim.
Clinical tracking data from 2026 shows Rejuran experienced plus 93,800% treatment growth compared to the same period the previous year. That figure is not a rounding error or a statistical anomaly. It reflects a genuine, global surge in patient demand for a treatment that has been available clinically for over two decades in South Korea, where it originated and where it has been one of the most widely used aesthetic treatments for years and is now reaching mainstream awareness in London and across Europe for the first time.

At Skin Lab Medispa in Marylebone and Old Street, Rejuran is one of the four polynucleotide brands we offe, and one of the most consistently impressive in terms of clinical results. Here is why the growth is happening and what it means for patients considering their next aesthetic treatment.
What Is Rejuran and How Does It Work?
Rejuran is a polynucleotide bio-stimulator derived from purified salmon DNA fragments, specifically polydeoxyribonucleotide, or PDRN. It works by signalling your skin's own fibroblast cells to repair, regenerate, and produce new collagen. Unlike dermal fillers which add volume, or skin boosters which primarily restore hydration, Rejuran works at a cellular level, improving the biological quality of the skin from within.
The mechanism is well established. PDRN has been used in wound healing and tissue repair in clinical medicine for decades. Its application in aesthetic medicine represents the translation of a proven regenerative mechanism into a skin quality context, which is why the clinical evidence base for Rejuran is significantly stronger than for most aesthetic treatments of comparable age.
The results develop gradually over six to eight weeks following each session and continue building for months after completing the course, because they are the product of your own skin's regenerative biology rather than an injected substance.
The Two Rejuran Formulations and Which Is Right for Which Concern:
Rejuran H uses a higher viscosity formulation designed for deeper skin regeneration and comprehensive facial treatment. It is particularly effective for patients with overall skin quality concerns, loss of firmness, uneven texture, dullness, fine lines across the full face where a broad regenerative stimulus produces the most significant improvement. At Skin Lab Medispa Rejuran H is available from £345 per session.
Rejuran I uses a lower viscosity formulation specifically designed for the delicate periorbital area, the thin, sensitive skin surrounding the eye. It is the most clinically established under-eye polynucleotide treatment available and is specifically indicated for fine lines, crepey texture, skin thinning, and early dark circles caused by skin quality deterioration rather than volume loss. At Skin Lab Medispa Rejuran I is available from £350 per session.
A course of three sessions spaced two to four weeks apart is recommended for both formulations, with results continuing to improve for several months after completing the course. Maintenance every six to twelve months sustains the outcome long term.
Why the Growth Is Happening Now and What Changed:
Rejuran has been available in South Korea for over twenty years, where clinical data accumulated over decades confirmed its safety and efficacy for skin regeneration. Its arrival in the European and UK aesthetic market is relatively recent, which explains why patient awareness is growing so rapidly now despite the product's long clinical history.
The broader shift driving Rejuran's growth is the movement away from volume-based aesthetics toward regenerative medicine. Patients are asking for treatments that make their skin work harder rather than fill a gap, and Rejuran answers that question more directly than almost any other treatment available. It does not add anything. It repairs and rebuilds.
The natural-looking result this produces is part of the appeal. Patients who have been reluctant to consider aesthetic treatment because they are worried about looking overdone or obviously treated find Rejuran's gradual, completely natural improvement exactly what they were looking for.
Why International Patients Are Travelling to London for Rejuran:
Rejuran is not FDA approved in the United States. American and Canadian patients cannot access Rejuran through legitimate medical channels at home regardless of where they live or what they are willing to spend. London offers regulated, medically led access to Rejuran using CE-marked products with an extensive published clinical evidence base.
Patients visiting from Australia and Europe have increasingly incorporated Rejuran appointments into London visits, particularly as awareness of the treatment has grown through social media and word of mouth among aesthetically informed patient communities internationally.
At Skin Lab Medispa we offer virtual consultations via WhatsApp video for international patients before their London visit, available across US Eastern, Pacific, Canadian, Central European, and Australian Eastern time zones. WhatsApp: wa.me/447899642951
10% Off Rejuran This September:
Throughout September Skin Lab Medispa is offering 10% off all skin treatments at both our Marylebone and Old Street clinics, including Rejuran H and Rejuran I. This applies to single sessions and to full courses.
Rejuran H from £345 — 10% off this September from £310
Rejuran I from £350 — 10% off this September from £315
Course of three Rejuran H — normally £1,035 — 10% off from £931
Same-week appointments available at our Marylebone clinic at Light Centre, 4 Baker Street, London W1H 6AZ and our Old Street clinic at Light Centre, 5 Singer Street, London EC2A 4BQ.
Book your Rejuran consultation: https://www.skinlabmedispa.co.uk/book-online
WhatsApp for virtual consultation: wa.me/447899642951
Found this helpful? Add Skin Lab Medispa as a Google Preferred Source: google.com/preferences/source?q=skinlabmedispa.co.uk




Comments